The administration says it will run out of money for monoclonal antibodies and other treatments and need a cash influx to secure additional boosters that might be recommended for the general population later this year.
Senate virus deal in limbo as GOP pushes for border-measure vote
→
The administration says it has enough money for the additional booster shots that Food and Drug Administration regulators authorized for persons over 50.
White House calls on Congress to pass COVID-19 deal immediately
→